
The Investor Way
The Investor Way
The Investor Way is a weekly investing podcast focused on UK stocks and shares.
E297 - Haleon, Reckitt Benckiser, Magnum, Unilever, GSK & Coca-Cola
Episode discussion: Analysts review Q3 trading updates for Haleon, Reckitt, Magnum, Unilever, GSK, and Coca-Cola
Speakers’ claims: Sam Ball and Jonathan McEwen analyze recent financial results for six consumer goods and pharmaceutical companies. They highlight Haleon's organic revenue growth driven by oral health and its share buyback program. Reckitt Benckiser reported a beat on net revenue and operating profit despite cost inflation, while Magnum upgraded its full-year growth outlook. Unilever and GSK both showed sales growth, with Unilever upgrading guidance and GSK citing specialty medicines. Coca-Cola beat consensus with strong volume growth and raised its full-year guidance.
E296 - RELX, Dominos, LSEG, Auction Technology Group, Sainsbury's & SpaceX
Episode discussion: Hosts favor LSEG and Sainsbury's over SpaceX, citing valuation concerns and AI infrastructure risks.
Speakers’ claims: The hosts analyze Q3 results for RELX, Domino's UK, LSEG, Auction Technology Group, and Sainsbury's, generally viewing them as fairly valued or attractive relative to peers. They express significant caution regarding SpaceX, highlighting its massive capital expenditure, high valuation, and potential dilution risks despite strong revenue growth in its AI infrastructure unit. LSEG is identified as the top pick due to its data assets and attractive valuation, while SpaceX is named the least favorite due to operational uncertainties and extreme multiples.